Your account is not claimed yet. You can sign up with ORCID to claim your account.

Rakesh Sathish Nair (Rakesh Nair, Ammara Naveed)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Patient Reported Outcomes

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Sandeep Kumar, Subhasis Das, Jingjing Sun, Yixian Huang, Sunil Kumar Singh, Piush Srivastava, Gautam Sondarva, Rakesh Sathish Nair, Navin Viswakarma, Balaji B Ganesh, Lei Duan, Carl G Maki, Kent Hoskins, Oana Danciu, Basabi Rana, Song Li, Ajay Rana
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2 + breast cancer by ceramide-loaded nanoparticles. Proceedings of the National Academy of Sciences of the United States of America 119 (38) (2022)
Michelle T Martin, Nicole Waring, Rakesh Sathish Nair
High Real-World Sustained Virologic Response Rate with Glecaprevir/Pibrentasvir at a Racially Diverse Urban Academic Medical Center. Gut and liver 16 (3) (2022)
Daniel R Principe, Alexandre Ferro Aissa, Sandeep Kumar, Thao N D Pham, Patrick W Underwood, Rakesh Sathish Nair, Rong Ke, Basabi Rana, Jose G Trevino, Hidayatullah G Munshi, Elizaveta V Benevolenskaya, Ajay Rana
Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Sunil Kumar Singh, Sandeep Kumar, Navin Viswakarma, Daniel R Principe, Subhasis Das, Gautam Sondarva, Rakesh Sathish Nair, Piush Srivastava, Subhash C Sinha, Paul J Grippo, Gregory R J Thatcher, Basabi Rana, Ajay Rana
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3. Oncogene 40 (43) (2021)